10 Results for "

CCKBR

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "CCKBR" in MCE Product Catalog:

  • Isoforms Recommended:
2
2 Cited Publications
Cat. No.: HY-103355
CAS No.: 145084-28-2
Purity:  99.87%
Target:  

CCR

Research Areas:  

Metabolic Disease

YM022 is a highly potent, selective and orally active gastrin/cholecystokinin (CCK)-B receptor (CCK-BR) antagonist. YM022 shows the Ki values of 68 pM and 63 nM for CCK-B and CCK-A receptor, respectively . YM022 can inhibit gastrin-induced gastric acid secretion and histidine decarboxylase activation in vivo .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P2671
CAS No.: 39024-57-2
Research Areas:  

Cancer

[Leu15]-Gastrin I (human) is a Gastrin I, human (HY-P1097) peptide hormone derivative, which is trophic for normal gastrointestinal epithelium. Gastrin stimulates growth of gastric adenocarcinoma (gastric cancer) through G-protein-coupled receptor called the cholecystokinin (CCK) or cholecystokinin-B receptors (CCK-BR) that are overexpressed in this malignancy. [Leu15]-Gastrin I (human) is promising for research of gastric cancer .
loading...
    loading...
Cat. No.: HY-P11540
CAS No.: 2923120-30-1
CCKBR agonist-1 (Compound 3r1) is a Gq-protein-preferring cholecystokinin B receptor (CCKBR) agonist with an EC50 of 35 pM. CCKBR agonist-1 significantly increases the survival rate of neurons, with an EC50 of 37 pM. CCKBR agonist-1 can improve the cognitive decline in mice by upregulating α-secretase (ADAM10) and calcium signaling molecule PLCB4, reduce the number of amyloid β () plaques, and promote long-term potentiation (LTP). CCKBR agonist-1 can be used for the study of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-RS02078
Research Areas:  

Others

Cckbr Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cckbr gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-160045
Research Areas:  

Cancer

AP1153 aptamer sodium is a DNA aptamer that specifically binds to the cholecystokinin receptor CCKBR (Kd: ~15 pM), but does not activate CCKBR-related signaling pathways. AP1153 aptamer sodium is internalized by pancreatic ductal adenocarcinoma (PDAC) cells in a receptor-mediated manner. AP1153 aptamer sodium can bioconjugate to the surface of fluorescent nanoparticles to facilitate nanoparticle delivery to PDAC tumors in vivo .
loading...
    loading...
Cat. No.: HY-RS02077
Research Areas:  

Others

CCKBR Human Pre-designed siRNA Set A contains three designed siRNAs for CCKBR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS02079
Research Areas:  

Others

Cckbr Rat Pre-designed siRNA Set A contains three designed siRNAs for Cckbr gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-179721
CAS No.: 923714-61-8
Research Areas:  

Neurological Disease

CCKBR agonist-2 (Compound z-44) is a Gi-preferring CCKBR agonist. CCKBR agonist-2 effectively activates the CCKBR-Gi signaling pathway (EC50 = 0.27 nM), but has almost no activity on Gq and Gs signaling pathways. CCKBR agonist-2 shows no significant protective effect in the mouse Alzheimer's disease model, proving that the simple activation of the Gi signal pathway does not play a dominant role in the improvement of cognitive function .
loading...
    loading...
Cat. No.: HY-P810854
Synonyms: CCKRB, CCKBR, Gastrin/cholecystokinin type B receptor, CCK-B receptor, CCK-BR, Cholecystokinin-2 receptor, CCK2-R

Host:  

Rabbit

Application:  

WB, ICC/IF

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-103355R
CAS No.: 145084-28-2
Target:  

Reference Standards CCR

Research Areas:  

Metabolic Disease

YM022 (Standard) is the analytical standard of YM022 (HY-103355). This product is intended for research and analytical applications. YM022 is a highly potent, selective and orally active gastrin/cholecystokinin (CCK)-B receptor (CCK-BR) antagonist. YM022 shows the Ki values of 68 pM and 63 nM for CCK-B and CCK-A receptor, respectively . YM022 can inhibit gastrin-induced gastric acid secretion and histidine decarboxylase activation in vivo .
loading...
    loading...